U.S. markets open in 2 hours 30 minutes
  • S&P Futures

    4,154.50
    -14.50 (-0.35%)
     
  • Dow Futures

    34,192.00
    -126.00 (-0.37%)
     
  • Nasdaq Futures

    13,331.00
    -56.00 (-0.42%)
     
  • Russell 2000 Futures

    2,205.40
    -17.30 (-0.78%)
     
  • Crude Oil

    65.28
    -0.09 (-0.14%)
     
  • Gold

    1,849.90
    +11.80 (+0.64%)
     
  • Silver

    27.74
    +0.37 (+1.35%)
     
  • EUR/USD

    1.2170
    +0.0024 (+0.19%)
     
  • 10-Yr Bond

    1.6350
    0.0000 (0.00%)
     
  • Vix

    20.63
    -2.50 (-10.81%)
     
  • GBP/USD

    1.4097
    -0.0005 (-0.04%)
     
  • USD/JPY

    109.1310
    -0.2160 (-0.20%)
     
  • BTC-USD

    44,521.94
    -5,061.39 (-10.21%)
     
  • CMC Crypto 200

    1,238.12
    -120.44 (-8.87%)
     
  • FTSE 100

    6,999.20
    -44.41 (-0.63%)
     
  • Nikkei 225

    27,824.83
    -259.67 (-0.92%)
     

Arbutus Biopharma (ABUS) Q4 2020 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·32 min read
Arbutus Biopharma (ABUS) Q4 2020 Earnings Call Transcript
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation fourth-quarter and year-end 2020 financial results and corporate update conference call. Good morning, and thank you for joining the Arbutus Biopharma fourth-quarter 2020 conference call and webcast. On the call today are Bill Collier, president and chief executive officer; Dr. Gaston Picchio, chief development officer; Dr. Michael Sofia, chief scientific officer; and Dave Hastings, chief financial officer.